Effect of cyclical therapy with phosphorus and etidronate on axial bone mineral density in postmenopausal osteoporotic women
- 1 June 1991
- journal article
- Published by Springer Nature in Osteoporosis International
- Vol. 1 (3) , 171-176
- https://doi.org/10.1007/bf01625449
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Measurement of vertebral area on spine X-rays in osteoporosis: Reliability of digitizing techniquesJournal of Bone and Mineral Research, 1990
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Fluoride and Bone — Quantity versus QualityNew England Journal of Medicine, 1990
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- Abnormalities in Parathyroid Hormone Secretion and 1,25-Dihydroxyvitamin D3Formation in Women with OsteoporosisNew England Journal of Medicine, 1989
- Age and bone mass as predictors of fracture in a prospective study.Journal of Clinical Investigation, 1988
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Involutional OsteoporosisNew England Journal of Medicine, 1986
- Effects of ethane-1 hydroxy-1, 1-Diphosphonate (5 mg/kg/day dose) onquantitative bone histology in paget's disease of boneMetabolic Bone Disease and Related Research, 1981
- BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPYThe Lancet, 1981